Deep Track Capital
Greenwich, Connecticutdeeptrackcapital.com
Overview
Deep Track Capital is a Greenwich, Connecticut-based investment firm founded in 2020 that focuses exclusively on the life sciences industry. The firm invests in both public and pre-IPO biotechnology companies, developing long-term partnerships with management teams. Its investment strategy includes leading transactions, building large syndicates, and investing in rounds led by other investors. The firm's primary focus is on biotechnology, pharmaceuticals, medical devices, diagnostics, and life sciences companies. Deep Track Capital is registered with the SEC as an investment adviser.
Portfolio Companies
37
Website
deeptrackcapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Terremoto | Apr 2026 | Series C | Co-investor |
| Obsidian Therapeutics | Apr 2026 | Private Placement | Co-investor |
| Ambrosia Biosciences Inc. | Mar 2026 | Series B | Lead |
| Ambrosia Bio | Mar 2026 | Series B | Lead |
| Cybin | Mar 2026 | Private Placement | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.